Breast cancer—epidemiology, risk factors, and genetics

With 1 million new cases in the world each year, breast cancer is the commonest malignancy in women and comprises 18% of all female cancers. In the United Kingdom, where the age standardised incidence and mortality is the highest in the world, the incidence among women aged 50 approaches two per 1000 women per year, and the disease is the single commonest cause of death among women aged 40-50, accounting for about a fifth of all deaths in this age group. There are more than 14 000 deaths each year, and the incidence is increasing particularly among women aged 50-64, probably because of breast screening in this age group. #### Worldwide incidence of cancers in women (1980) View this table: Worldwide incidence of cancers in women (1980) Of every 1000 women aged 50, two will recently have had breast cancer diagnosed and about 15 will have had a diagnosis made before the age of 50, giving a prevalence of breast cancer of nearly 2%. ### Age The incidence of breast cancer increases with age, doubling about every 10 years until the menopause, when the rate of increase slows dramatically. Compared with lung cancer, the incidence of breast cancer is higher at younger ages. In some countries there is a flattening of the age-incidence curve after the menopause. Percentage of all deaths in women attributable to breast cancer Standardised mortality for breast cancer in different countries ### Geographical variation Age adjusted incidence and mortality for breast cancer varies by up to a factor of five between countries. The difference between Far Eastern and Western countries is diminishing but is still about fivefold. Studies of migrants from Japan to Hawaii show that the rates of breast cancer in migrants assume the rate in the host country within one or two generations, indicating that environmental factors are of greater importance than genetic factors. Age specific incidence and mortality for …

[1]  Costantino Mj,et al.  Prevention of breast cancer. , 1989 .

[2]  H T Lynch,et al.  Hereditary breast cancer. , 1991, Annals of medicine.

[3]  C. Elston,et al.  Disease of the breast , 1998 .

[4]  M. Morrow,et al.  The woman at increased risk for breast cancer: Evaluation andmanagement strategies , 1995, CA: a cancer journal for clinicians.

[5]  D. Decker Prophylactic mastectomy for familial breast cancer. , 1993, JAMA.

[6]  C. D. HAAGENSEN,et al.  Diseases of the Breast , 1972 .

[7]  T. Powles,et al.  Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial , 1998, The Lancet.

[8]  Julian Peto,et al.  Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies , 1996, The Lancet.

[9]  C K Redmond,et al.  Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. , 1999, Journal of the National Cancer Institute.

[10]  M. Skolnick,et al.  BRCA1 mutations in primary breast and ovarian carcinomas. , 1994, Science.

[11]  M. Greene,et al.  Genetics of breast cancer. , 1997, Mayo Clinic proceedings.

[12]  Mafee Mf Imaging methods for sinusitis. , 1993 .

[13]  P. Boyle,et al.  Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomised women , 1998, The Lancet.